![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Present at the 24th Annual Roth Conference
March 09, 2012 10:48 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 9, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Announces Fourth Quarter and Full Year 2011 Results
February 16, 2012 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Release Q4 and Full Year 2011 Results and Hold Investor Call on Thursday, February 16
February 06, 2012 16:52 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its results...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Receives FDA Clearance of Gram-Positive Blood Culture Test for Staphylococcus
December 27, 2011 14:25 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Dec. 27, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today it has...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Obtains CE Mark for Gram-Positive Blood Culture Test
December 20, 2011 17:26 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Dec. 20, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today it has...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Present at Piper Jaffray 23rd Annual Healthcare Conference
November 29, 2011 13:07 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 29, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Present at Stephens Inc. Fall Investment Conference
November 09, 2011 17:14 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 9, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Announces Third Quarter 2011 Results
November 02, 2011 16:05 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Release Q3 2011 Results and Hold Investor Call on Wednesday, November 2
October 18, 2011 13:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 18, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere's Verigene Gram-Positive Blood Culture Test Demonstrates High Sensitivity and Specificity for a Broad Panel of Bacterial Targets
September 19, 2011 16:12 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Nanosphere's (Nasdaq:NSPH) Verigene BC-GP test, based on the company's proprietary array-based nanoparticle technology, demonstrated 100%...